US blocks entry of three current, former Paraguayan officials...

In the key northeastern region of Adamawa -- which could see the election of Nigeria's first woman governor -- the results were declared "inconclusive" as the number of voters unable to cast their ballot was greater than the margin between the two fro

The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).

"While the IOC has made no final decisions yet, we strongly urge it to reconsider its plans and return to the original well-proven stance supported by the international community," the Polish statement said.

March 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S.
Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol.